Semi-analytical approach for the Vaidya metric in double-null coordinates

We reexamine here a problem considered in detail before by Waugh and Lake: the solutions of spherically symmetric Einstein's equations with a radial flow of unpolarized radiation (the Vaidya metric) in double-null coordinates. This problem is known to be not analytically solvable, the only known explicit solutions correspond to the constant mass case (Schwarzschild solution in Kruskal-Szekeres form) and the linear and exponential mass functions originally discovered by Waugh and Lake. We present here a semi-analytical approach that can be used to discuss some qualitative and quantitative aspects of the Vaidya metric in double-null coordinates for generic mass functions. We present also a new analytical solution corresponding to $(1/v)$-mass function.Comment: 5 pages, 6 figure

Spin melting and refreezing driven by uniaxial compression on a dipolar hexagonal plate

We investigate freezing characteristics of a finite dipolar hexagonal plate by the Monte Carlo simulation. The hexagonal plate is cut out from a piled triangular lattice of three layers with FCC-like (ABCABC) stacking structure. In the present study an annealing simulation is performed for the dipolar plate uniaxially compressed in the direction of layer-piling. We find spin melting and refreezing driven by the uniaxial compression. Each of the melting and refreezing corresponds one-to-one with a change of the ground states induced by compression. The freezing temperatures of the ground-state orders differ significantly from each other, which gives rise to the spin melting and refreezing of the present interest. We argue that these phenomena are originated by a finite size effect combined with peculiar anisotropic nature of the dipole-dipole interaction.Comment: Proceedings of the Highly Frustrated Magnetism (HFM2006) conference. To appear in a special issue of J. Phys. Condens. Matte

Treating cisplatin-resistant cancer: a systematic analysis of oxaliplatin or paclitaxel salvage chemotherapy

Objective: To examine the pre-clinical and clinical evidence for the use of oxaliplatin or paclitaxel salvage chemotherapy in patients with cisplatin-resistant cancer. Methods: Medline was searched for 1) Cell models of acquired resistance reporting cisplatin, oxaliplatin and paclitaxel sensitivities and 2) Clinical trials of single agent oxaliplatin or paclitaxel salvage therapy for cisplatin/carboplatin-resistant ovarian cancer. Results: Oxaliplatin - Oxaliplatin is widely regarded as being active in cisplatin-resistant cancer. In contrast, data in cell models suggests that there is cross-resistance between cisplatin and oxaliplatin in cellular models with resistance levels which reflect clinical resistance (<10 fold). Oxaliplatin as a single agent had a poor response rate in patients with cisplatin-resistant ovarian cancer (8%, n=91). Oxaliplatin performed better in combination with other agents for the treatment of platinum-resistant cancer suggesting that the benefit of oxaliplatin may lie in its more favourable toxicity and ability to be combined with other drugs rather than an underlying activity in cisplatin resistance. Oxaliplatin therefore should not be considered broadly active in cisplatin-resistant cancer. Paclitaxel – Cellular data suggests that paclitaxel is active in cisplatin-resistant cancer. 68.1% of cisplatin-resistant cells were sensitive to paclitaxel. Paclitaxel as a single agent had a response rate of 22% in patients with platinum-resistant ovarian cancer (n = 1918), a significant increase from the response of oxaliplatin (p<0.01). Paclitaxel-resistant cells were also sensitive to cisplatin, suggesting that alternating between agents may be beneficial. Studies of single agent paclitaxel in platinum-resistant ovarian cancer where patients had previously received paclitaxel had an improved response rate of 35.3% n=232 (p<0.01), suggesting that pre-treatment with paclitaxel improves the response of salvage paclitaxel therapy. Conclusions: Cellular models reflect the resistance observed in the clinic as the cross resistant agent oxaliplatin has a lower response rate compared to the non-cross resistant agent paclitaxel in cisplatin-resistant ovarian cancer. Alternating therapy with cisplatin and paclitaxel may therefore lead to an improved response rate in ovarian cancer

Angle-resolved photoemission spectroscopy of Co-based boride superconductor LaCo1.73Fe0.27B2

We have performed angle-resolved photoemission spectroscopy of Co-based boride superconductor LaCo1.73Fe0.27B2 (Tc = 4.1 K), which is isostructural to the 122-type Fe-pnictide superconductor with the pnictogen atom being replaced with boron. We found that the Fermi level is located at a dip in the density of states (DOS) in contrast to Co-pnictide ferromagnets. This reduction in DOS together with the strong Co 3d-B 2p covalent bonding removes the ferromagnetic order and may cause the superconductivity. The energy bands near the Fermi level show higher three dimensionality and a weaker electron-correlation effect than those of Fe pnictides. The Fermi surface topology is considerably different from that of Fe pnictides, suggesting the difference in the superconducting mechanism between boride and pnictide superconductors.Comment: 5 pages, 4 figure

<Preliminary>0-methyltransferase (OMT) cDNA Clones from Pinus densiflora Seedlings

この論文は国立情報学研究所の学術雑誌公開支援事業により電子化されました